Pharmacogenomics: introduction and use in clinical practice

Area of Science:

• Pharmacogenomics
• Genetics
• Drug Metabolism

Background:

• Pharmacogenomics is the study of how genes affect a person's response to drugs.
• Understanding genetic variations is crucial for optimizing drug therapy and minimizing adverse drug reactions.
• The field is rapidly advancing, with increasing interest and accessibility.

Purpose of the Study:

• To explain the basic principles of pharmacodynamics and pharmacokinetics in relation to drug response.
• To review gene-drug pairings for commonly prescribed medications.
• To guide interpretation of pharmacogenomic reports, including indications and limitations.

Main Methods:

• Review of scientific literature on pharmacogenomics, pharmacodynamics, and pharmacokinetics.
• Analysis of gene-drug interactions for selected medications.
• Discussion of direct-to-consumer pharmacogenomic testing and FDA guidelines.

Main Results:

• Genetic variations significantly influence drug efficacy, dosage, and potential for adverse effects.
• Knowledge of gene-drug pairings allows for tailored medication selection.
• Direct-to-consumer testing is available, but FDA guidelines are limited.

Conclusions:

• Pharmacogenomics is a key component of individualized medicine.
• Tailoring drug therapy based on genetic makeup can predict safer and more effective patient responses.
• Further understanding and application of pharmacogenomics are essential for clinical practice.